Vericel Corporation engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee. Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal. NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-th thickness.
Aastrom Biosciences today announced the change of its corporate name to Vericel Corporation ("Vericel"), effective immediately. The name change has been approved by the company's shareholders.
Ticker:
VCEL
ISIN:
US92346J1088
Address:
Domino's Farms, Lobb (click to copy or hover over here to view full address)